三生国健股价连续5天下跌累计跌幅6.83%，中银基金旗下1只基金持66.07万股，浮亏损失286.73万元

Group 1 - The core point of the news is that Sangfor Technologies has experienced a continuous decline in stock price, dropping 0.52% to 59.19 CNY per share, with a total market capitalization of 36.585 billion CNY and a cumulative decline of 6.83% over the past five days [1] - Sangfor Technologies, established on January 25, 2002, and listed on July 22, 2020, is primarily engaged in the research, production, and sales of antibody drugs, with its main business revenue composition being 75.24% from product sales, 15.37% from commissioned processing services, 7.94% from licensing, and 1.44% from leasing services [1] Group 2 - According to data from the top ten holdings of funds, one fund under Bank of China, the Bank of China Healthcare Mixed A Fund (005689), has increased its holdings in Sangfor Technologies by 13,900 shares, bringing the total to 660,700 shares, which represents 6.21% of the fund's net value, making it the fourth-largest holding [2] - The Bank of China Healthcare Mixed A Fund has a current scale of 471 million CNY and has reported a loss of 1.25% year-to-date, ranking 8275 out of 8874 in its category, while achieving a one-year return of 58.53%, ranking 1083 out of 8124 [2] - The fund manager, Zheng Ning, has been in charge for 3 years and 219 days, with the fund's total assets amounting to 7.703 billion CNY, achieving the best return of 65.74% and the worst return of 38.63% during his tenure [2]